{
  "id": "upd-2026-ml44mszm",
  "type": "update",
  "status": "rejected",
  "createdAt": "2026-02-01T19:21:26.338Z",
  "createdBy": "daemon",
  "reviewedAt": "2026-02-01T19:30:00.000Z",
  "reviewedBy": "alex",
  "appliedAt": null,
  "rejectionReason": "Redundant - PATHFINDER-2 data already in database",
  "testName": "Galleri",
  "testId": null,
  "changes": {
    "clinicalEvidence": {
      "trialName": "PATHFINDER 2",
      "nctId": null,
      "publication": null,
      "findings": "Galleri Multi-Cancer Early Detection Blood Test increased cancer detection more than seven-fold when added to USPSTF A and B recommended screenings. More than half of cancers detected by Galleri were early stage. Approximately three-quarters of Galleri-detected cancers do not have recommended screenings.",
      "date": "2025-10-17"
    }
  },
  "source": "https://www.grail.com/press-releases",
  "sourceTitle": "GRAIL: PATHFINDER 2",
  "confidence": 0.75,
  "snippet": "Galleri Multi-Cancer Early Detection Blood Test increased cancer detection more than seven-fold when added to USPSTF A and B recommended screenings. More than half of cancers detected by Galleri were early stage. Approximately three-quarters of Galleri-detected cancers do not have recommended screenings."
}
